Both sides previous revisionPrevious revisionNext revision | Previous revisionBoth sides next revision |
american_association_for_cancer_research [2023/05/11 07:04] liam | american_association_for_cancer_research [2023/05/11 08:10] (current) liam [Funding] |
---|
| |
===== History ===== | ===== History ===== |
| |
| [[Pamela Ohashi]], AACR's Tumor Immunotherapy Program director, participated in the [[COVID-19 Therapeutics Task Force]] convened by [[Innovation, Science and Economic Development Canada]] (ISED).((Innovation, Science and Economic Development Canada. (2022, March 10). //COVID-19 Therapeutics Task Force.// Government of Canada. http://archive.today/2023.04.27-230206/https://ised-isde.canada.ca/site/canadian-life-science-industries/en/covid-19-therapeutics-task-force)) |
| |
In the first half of 2021, AACR received four grants from [[pharmaceutical_companies:Pfizer]]:((//US Medical, Scientific, Patient and Civic Organization Funding Report: Q1-Q2 2021.// (2021, September 27). Pfizer. https://web.archive.org/web/20230503211316/https://s3.documentcloud.org/documents/23787007/pfizer-2021-report.pdf)) | In the first half of 2021, AACR received four grants from [[pharmaceutical_companies:Pfizer]]:((//US Medical, Scientific, Patient and Civic Organization Funding Report: Q1-Q2 2021.// (2021, September 27). Pfizer. https://web.archive.org/web/20230503211316/https://s3.documentcloud.org/documents/23787007/pfizer-2021-report.pdf)) |
| |
| * 2021 Annual Meeting ($25,000) |
| * Conference on Science of Cancer Health Disparities ($10,000) |
| * Evolving Tumor Microenvironment in Cancer Progression: Mechanisms and Emerging Therapeutic Opportunities ($5,000) |
| * 2021 Scientist-Survivor Program ($10,000) |
| |
| ===== Organization ===== |
| |
| AACR is a member organization of the [[Alliance for a Stronger FDA]]((//List of Members.// (2022, March 4). Alliance for a Stronger FDA. http://archive.today/2022.07.08-045902/https://www.strengthenfda.org/members)) and a partner of the [[Society for Immunotherapy of Cancer]].((//Cancer Immunotherapy Partnerships and Collaborations.// Society for Immunotherapy of Cancer. Retrieved March 27, 2023, from https://web.archive.org/web/20230327191240/https://www.sitcancer.org/aboutsitc/partnerships#champions)) It has previously provided funding to the [[Dana-Farber Cancer Institute]].((Benz Jr., E. J., Paresky, S. S., Dana III, C. A., & Morse, R. P. //2012 Honor Roll of Donors.// PageTurnPro; Dana-Farber Cancer Institute. Retrieved August 13, 2022, from https://web.archive.org/web/20220813072451/https://www.pageturnpro.com/Dana-Farber-Cancer-Institute-and-The-Jimmy-Fund/49214-2012-Honor-Roll-of-Donors/sdefault.html#page/76)) |
| |
| ==== Personnel ==== |
| |
| ^ Name ^ Position ^ Notes ^ |
| | [[Pamela Ohashi]] | Director, Tumor Immunotherapy Program | [[COVID-19 Therapeutics Task Force]] | |
| |
| ==== Funding ==== |
| |
| AACR has received funding from:((//Supporters.// American Association for Cancer Research (AACR). Retrieved January 29, 2023, from http://archive.today/2023.05.11-051652/https://www.aacr.org/meeting/aacr-annual-meeting-2021/supporters/)) |
| |
| <WRAP column col4> |
| * [[pharmaceutical_companies:AbbVie]] |
| * [[American Cancer Society]] |
| * [[pharmaceutical_companies:Amgen]] |
| * [[pharmaceutical_companies:Astellas]] |
| * [[pharmaceutical_companies:AstraZeneca]] |
| * [[pharmaceutical_companies:BeiGene]] |
| * [[pharmaceutical_companies:Boehringer Ingelheim]] |
| * [[Breast Cancer Research Foundation]] |
| * [[pharmaceutical_companies:Bristol-Myers Squibb]] |
| * [[Cancer Research Institute]] (CRI) |
| * [[Colon Cancer Coalition]] |
| * [[pharmaceutical_companies:Daiichi-Sankyo]] |
| * [[Doreen H. Putrah Cancer Research Foundation]] |
| * [[pharmaceutical_companies:Eli Lilly]] |
| * [[pharmaceutical_companies:Exelixis]] |
| * [[FUJIFILM VisualSonics]] |
| * [[pharmaceutical_companies:Gilead Sciences]] |
| * [[pharmaceutical_companies:GlaxoSmithKline]] |
| * [[pharmaceutical_companies:Incyte]] |
| * [[Irving Weinstein Foundation]] |
| * [[pharmaceutical_companies:Jazz Pharmaceuticals]] |
| * [[pharmaceutical_companies:Kite Pharma]] |
| * [[pharmaceutical_companies:Merck]] |
| * [[pharmaceutical_companies:Novartis]] |
| * [[pharmaceutical_companies:Novocure]] |
| * [[Pezcoller Foundation]] |
| * [[pharmaceutical_companies:Pfizer]]((//US Medical, Scientific, Patient and Civic Organization Funding Report: Q1-Q2 2021.// (2021, September 27). Pfizer. https://web.archive.org/web/20230503211316/https://s3.documentcloud.org/documents/23787007/pfizer-2021-report.pdf)) |
| * [[pharmaceutical_companies:Promega]] |
| * [[Prostate Cancer Foundation]] |
| * [[pharmaceutical_companies:Sanofi Genzyme]] |
| * [[journals:Science]] |
| * [[journals:Science Translational Medicine]] |
| * [[pharmaceutical_companies:Seagen]] |
| * [[Silicon Valley Community Foundation]] (SVCF)((//Grants Catalog.// Silicon Valley Community Foundation. Retrieved February 4, 2022, from https://web.archive.org/web/20221204120848/https://www.siliconvalleycf.org/impact/grants-catalog)) |
| * [[St. Baldrick's Foudation]] |
| * [[pharmaceutical_companies:Sygnature Discovery]] |
| * [[pharmaceutical_companies:Taiho Oncology]] |
| * [[pharmaceutical_companies:Takeda]] |
| * [[pharmaceutical_companies:WuXi AppTec]] |
| </WRAP> |
===== External links ===== | ===== External links ===== |
| |
* [[https://en.wikipedia.org/wiki/American_Association_for_Cancer_Research|Wikipedia]] | * [[https://en.wikipedia.org/wiki/American_Association_for_Cancer_Research|Wikipedia]] |